^
    4ms
    A single arm, open clinical study to evaluate the safety, tolerance and initial efficacy of KM1 oncolytic vaccinia virus injection in the treatment of high-risk patients with recurrent non muscle invasive bladder cancer (ChiCTR2400086709)
    P1, N=18, Recruiting, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of | Not yet recruiting --> Recruiting
    Enrollment open
    |
    KM1
    over1year
    K19017-004: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer (clinicaltrials.gov)
    P1, N=30, Recruiting, Tongji Hospital | Not yet recruiting --> Recruiting
    Enrollment open • Oncolytic virus
    |
    Avastin (bevacizumab) • cisplatin • carboplatin • albumin-bound paclitaxel • KM1
    almost3years
    K19017-004: Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, Tongji Hospital
    New P1 trial • Oncolytic virus
    |
    MUC16 (Mucin 16, Cell Surface Associated)
    |
    Avastin (bevacizumab) • cisplatin • carboplatin • albumin-bound paclitaxel • KM1